| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2014PLoSO...980050J |
| P356 | DOI | 10.1371/JOURNAL.PONE.0080050 |
| P932 | PMC publication ID | 3885380 |
| P698 | PubMed publication ID | 24416126 |
| P5875 | ResearchGate publication ID | 259700745 |
| P2093 | author name string | Jung-Joon Min | |
| Jae Il Kim | |||
| Yeongjin Hong | |||
| Sun Chang Kim | |||
| Jeong-A Lim | |||
| Sangryeol Ryu | |||
| Daejin Lim | |||
| Hyon E Choy | |||
| Jae-Ho Jeong | |||
| Geun-Joong Kim | |||
| Vu H Nguyen | |||
| Tae-Hyoung Kim | |||
| Kwangsoo Kim | |||
| Kwangjoon Jeong | |||
| P2860 | cites work | The Molecular Mechanism of Noxa-induced Mitochondrial Dysfunction in p53-Mediated Cell Death | Q24294863 |
| Can engineered bacteria help control cancer? | Q24555059 | ||
| The Bcl-2 apoptotic switch in cancer development and therapy | Q24620437 | ||
| A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 | ||
| Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter | Q27860697 | ||
| One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products | Q27860842 | ||
| Magnetic resonance imaging of tumors colonized with bacterial ferritin-expressing Escherichia coli | Q28744347 | ||
| The biochemistry of apoptosis | Q29547741 | ||
| Heterologous protein secretion and the versatile Escherichia coli haemolysin translocator | Q40535584 | ||
| ppGpp-dependent stationary phase induction of genes on Salmonella pathogenicity island 1. | Q40552048 | ||
| Selective involvement of BH3-only proteins and differential targets of Noxa in diverse apoptotic pathways | Q42714125 | ||
| Deletion and fusion analysis of the phage phi X174 lysis gene E. | Q43444122 | ||
| Quantitative bioluminescence imaging of tumor-targeting bacteria in living animals | Q47794539 | ||
| A coupling process for improving purity of bacterial minicells by holin/lysin | Q50042417 | ||
| Containment of tumor-colonizing bacteria by host neutrophils | Q50062621 | ||
| Tumor-specific colonization, tissue distribution, and gene induction by probiotic Escherichia coli Nissle 1917 in live mice | Q50072406 | ||
| Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium | Q50120814 | ||
| Tumor-targeted Salmonella as a novel anticancer vector | Q50133173 | ||
| Cell lysis by induction of cloned lambda lysis genes | Q70557007 | ||
| The kil gene of the ColE1 plasmid of Escherichia coli controlled by a growth-phase-dependent promoter mediates the secretion of a heterologous periplasmic protein during the stationary phase | Q73302653 | ||
| Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration | Q77658726 | ||
| Improved single and multicopy lac-based cloning vectors for protein and operon fusions | Q29615296 | ||
| In vivo protein transduction: delivery of a biologically active protein into the mouse | Q29615482 | ||
| Mechanisms of phagocytosis in macrophages | Q29618100 | ||
| Insight into the mechanism of internalization of the cell-penetrating carrier peptide Pep-1 through conformational analysis. | Q30892744 | ||
| Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma | Q33340438 | ||
| Structure and hydration of membranes embedded with voltage-sensing domains | Q33516691 | ||
| Short-term signatures of evolutionary change in the Salmonella enterica serovar typhimurium 14028 genome | Q33586060 | ||
| Cell-penetrating peptides. | Q33846582 | ||
| Vectorial delivery of macromolecules into cells using peptide-based vehicles | Q34123245 | ||
| Unraveling immune privilege | Q34290452 | ||
| Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins | Q34301980 | ||
| Holins: form and function in bacteriophage lysis | Q34304886 | ||
| Cellular uptake of Antennapedia Penetratin peptides is a two-step process in which phase transfer precedes a tryptophan-dependent translocation | Q34460487 | ||
| Protein transduction technology | Q34534961 | ||
| Modeling the therapeutic efficacy of p53 restoration in tumors | Q34593294 | ||
| A novel balanced-lethal host-vector system based on glmS. | Q34654013 | ||
| Engineering and visualization of bacteria for targeting infarcted myocardium | Q34994526 | ||
| Cell and process design for targeting of recombinant protein into the culture medium of Escherichia coli | Q35094228 | ||
| A review of the influence of bacterial infection and of bacterial products (Coley's toxins) on malignant tumors in man; a critical analysis of 30 inoperable cases treated by Coley's mixed toxins, in which diagnosis was confirmed by microscopic exam | Q35222693 | ||
| The Bcl-2 family: roles in cell survival and oncogenesis. | Q35591695 | ||
| Structural biology of the Bcl-2 family of proteins | Q35680498 | ||
| Pharmacokinetic and pharmacodynamic properties of EGFR inhibitors under clinical investigation. | Q35732250 | ||
| NOXA as critical mediator for drug combinations in polychemotherapy | Q36071973 | ||
| Identification of the glmU gene encoding N-acetylglucosamine-1-phosphate uridyltransferase in Escherichia coli. | Q36122633 | ||
| Lysis protein S of phage lambda functions in Saccharomyces cerevisiae | Q36193616 | ||
| p53-based cancer therapies: Is defective p53 the Achilles heel of the tumor? | Q36646572 | ||
| Isolation and Characterization of a Glucosamine-Requiring Mutant of Escherichia coli K-12 Defective in Glucosamine-6-Phosphate Synthetase | Q36791547 | ||
| Mutant of Escherichia coli K-12 Defective in d -Glucosamine Biosynthesis | Q36791609 | ||
| Engineering the perfect (bacterial) cancer therapy | Q37131536 | ||
| Engineering of bacteria for the visualization of targeted delivery of a cytolytic anticancer agent | Q37316867 | ||
| Structure, function, and modification of the voltage sensor in voltage-gated ion channels | Q37319499 | ||
| The cell death-inducing activity of the peptide containing Noxa mitochondrial-targeting domain is associated with calcium release | Q38491865 | ||
| Use of lambda phage S and R gene products in an inducible lysis system for Vibrio cholerae- and Salmonella enterica serovar typhimurium-based DNA vaccine delivery systems | Q39514280 | ||
| Genetically engineered Salmonella typhimurium as an imageable therapeutic probe for cancer | Q39760012 | ||
| Therapeutic potential of proapoptotic molecule Noxa in the selective elimination of tumor cells | Q39870978 | ||
| Systemic administration of an attenuated, tumor-targeting Salmonella typhimurium to dogs with spontaneous neoplasia: phase I evaluation | Q40504400 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | mitochondrion | Q39572 |
| Salmonella Typhimurium | Q166491 | ||
| P304 | page(s) | e80050 | |
| P577 | publication date | 2014-01-08 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Anti-tumoral effect of the mitochondrial target domain of Noxa delivered by an engineered Salmonella typhimurium | |
| P478 | volume | 9 |
| Q40937873 | Activation of inflammasome by attenuated Salmonella typhimurium in bacteria-mediated cancer therapy |
| Q64124307 | Advances in bacterial cancer therapies using synthetic biology |
| Q33914020 | Anti-tumor activity of an immunotoxin (TGFα-PE38) delivered by attenuated Salmonella typhimurium |
| Q47547640 | Cell Penetrating Peptides as Molecular Carriers for Anti-Cancer Agents. |
| Q50317370 | Cell mass-dependent expression of an anticancer protein drug by tumor-targeted Salmonella |
| Q58121061 | Co-expression of a Chimeric Protease Inhibitor Secreted by a Tumor-targeted Protects Therapeutic Proteins from Proteolytic Degradation |
| Q89992810 | Design of Outer Membrane Vesicles as Cancer Vaccines: A New Toolkit for Cancer Therapy |
| Q89947898 | Development of Oxytolerant Salmonella typhimurium Using Radiation Mutation Technology (RMT) for Cancer Therapy |
| Q47126937 | Engineered Salmonella enterica serovar Typhimurium overcomes limitations of anti-bacterial immunity in bacteria-mediated tumor therapy |
| Q37134828 | Engineering Salmonella as intracellular factory for effective killing of tumour cells. |
| Q28543432 | Impediments to enhancement of CPT-11 anticancer activity by E. coli directed beta-glucuronidase therapy |
| Q38955988 | Improved cytotoxic effects of Salmonella-producing cytosine deaminase in tumour cells. |
| Q36838520 | L-Asparaginase delivered by Salmonella typhimurium suppresses solid tumors |
| Q91670549 | Live Attenuated Salmonella enterica Expressing and Releasing Cell-Permeable Bax BH3 Peptide Through the MisL Autotransporter System Elicits Antitumor Activity in a Murine Xenograft Model of Human B Non-hodgkin's Lymphoma |
| Q40163572 | Local application of bacteria improves safety of Salmonella -mediated tumor therapy and retains advantages of systemic infection. |
| Q35579375 | Potent and tumor specific: arming bacteria with therapeutic proteins |
| Q46247736 | Proteus mirabilis inhibits cancer growth and pulmonary metastasis in a mouse breast cancer model. |
| Q27015676 | Salmonella and cancer: from pathogens to therapeutics |
| Q36191597 | Salmonella typhimurium Suppresses Tumor Growth via the Pro-Inflammatory Cytokine Interleukin-1β. |
| Q39339432 | Salmonella-Mediated Cancer Therapy: Roles and Potential |
| Q28069354 | Targeted Cancer Therapy Using Engineered Salmonella typhimurium |
| Q37355548 | Tumor-targeted delivery of a C-terminally truncated FADD (N-FADD) significantly suppresses the B16F10 melanoma via enhancing apoptosis |
| Q58599910 | Tumour-targeting bacteria engineered to fight cancer |
| Q47587450 | Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous flagellin |
| Q88812394 | Ursolic acid facilitates apoptosis in rheumatoid arthritis synovial fibroblasts by inducing SP1-mediated Noxa expression and proteasomal degradation of Mcl-1 |
Search more.